Treatment with statins: cost-effectiveness considerations

被引：0
|
作者：
Verdecchia, Paolo [1 ]
机构：
[1] Osped R Silvestrini, Unita Ric Clin Cardiol Prevent, Struttura Complessa Cardiol, I-06156 Perugia, Italy
来源：
GIORNALE ITALIANO DI CARDIOLOGIA | 2006年 / 7卷 / 12期
关键词：
D O I：
10.1714/709.8099
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：22S / 27S
页数：6
相关论文
共 50 条
  • [1] Cost-effectiveness of statins
    Reckless, JPD
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2000, 11 (04) : 351 - 356
  • [2] Cost-effectiveness of statins
    Huse, DM
    Russell, MW
    Miller, JD
    Kraemer, DF
    D'Agostino, RB
    Ellison, RC
    Hartz, SC
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (11): : 1357 - 1363
  • [3] Cost-effectiveness considerations in otitis media treatment
    Gates, GA
    [J]. RECENT ADVANCES IN OTITIS MEDIA, 1996, : 1 - 4
  • [4] Cost-effectiveness considerations in the treatment of essential thrombocythemia
    Golub, R
    Adams, J
    Dave, S
    Bennett, CL
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (03) : 28 - 32
  • [5] Cost-effectiveness considerations in otitis media treatment
    Gates, GA
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1996, 114 (04) : 525 - 530
  • [6] A systematic review on the cost-effectiveness of statins
    Franco, O
    Bonneux, L
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 : 463 - 463
  • [7] AUTOTRANSFUSION - COST-EFFECTIVENESS CONSIDERATIONS
    ORR, MD
    BLENKO, J
    [J]. INTENSIVE CARE MEDICINE, 1977, 3 (03) : 215 - 215
  • [8] Cost-effectiveness considerations at NICE
    Rawlins, Michael
    Dillon, Andrew
    [J]. LANCET, 2008, 372 (9646): : 1302 - 1302
  • [9] The price of a QALY—cost-effectiveness of statins in CKD
    Vivekanand Jha
    Gopesh K. Modi
    [J]. Nature Reviews Nephrology, 2013, 9 : 377 - 379
  • [10] Statins: Pharmacokinetics, Pharmacodynamics and Cost-Effectiveness Analysis
    Ricci, Gabriella
    Ciccone, Marco Matteo
    Giordano, Paola
    Cortese, Francesca
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (03) : 213 - 221
12345